US Broker Ratings

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Promising Revenue Growth and Analyst Confidence

TG Therapeutics, Inc. (NASDAQ: TGTX) has positioned itself as a formidable entity within the biotechnology sector, especially given its focus on innovative treatments for B-cell mediated diseases. Headquartered in Morrisville,..

Sanofi (SNY) Stock Analysis: Exploring a Strong Dividend Yield and 26% Potential Upside

Sanofi (SNY), a global leader in the healthcare sector, primarily operates in the pharmaceutical industry, focusing on drug manufacturing. With its headquarters in Paris, France, Sanofi’s influence extends worldwide through..

Encompass Health Corporation (EHC) Stock Analysis: Uncovering a 38% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Encompass Health Corporation (NYSE: EHC) presents a compelling case with its robust growth trajectory and promising analyst ratings. Currently trading at $101.47,..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Uncovering a 14.47% Upside Potential in the Healthcare Sector

For investors eyeing opportunities within the healthcare sector, Smith & Nephew SNATS, Inc. (NYSE: SNN) presents an intriguing option. With a rich history dating back to 1856, Smith & Nephew..

Nuvalent, Inc. (NUVL) Stock Analysis: Assessing the 3.96% Potential Upside Amidst Biotech Innovation

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company specializing in groundbreaking cancer therapies, stands at the forefront of the biotechnology industry. With a market capitalization of $9.75 billion, the company..

Solventum Corporation (SOLV) Stock Analysis: Unpacking a 4.16% Potential Upside in the Healthcare Sector

Solventum Corporation (NASDAQ: SOLV) stands as a notable player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $13.66 billion, Solventum has carved out..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a Potential 29.97% Upside in Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV), a pioneering force in the biotechnology sector, stands at the forefront of developing groundbreaking treatments for a variety of autoimmune and cardiopulmonary diseases. With its..

Universal Health Services (UHS) Stock Analysis: Exploring a 47% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands out in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $8.86 billion, UHS has established itself..

Takeda Pharmaceutical Company (TAK) Stock Analysis: A 30% Upside Potential Beckons Investors

Takeda Pharmaceutical Company Limited (NYSE: TAK) has long been a formidable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of..

The Cigna Group (CI) Stock Analysis: Exploring a 14.4% Upside Potential in the Healthcare Sector

The Cigna Group (CI), a stalwart in the healthcare sector, presents a compelling investment opportunity with a potential upside of 14.4% according to analyst expectations. This article dives into the..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Robust Revenue Growth and Strategic Positioning in Healthcare

Medpace Holdings, Inc. (NASDAQ: MEDP) stands out in the healthcare sector as a formidable player in the diagnostics and research industry. With a market capitalization of $13.35 billion, Medpace has..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unlocking a 34.59% Potential Upside in Healthcare Innovation

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the medical instruments and supplies sector, offers a compelling investment opportunity with a potential upside of 34.59%. With a market..

Axsome Therapeutics (AXSM) Stock Analysis: 57% Revenue Growth Propels Exciting Prospects

Investors have been closely watching Axsome Therapeutics, Inc. (NASDAQ: AXSM), a burgeoning player in the biotechnology sector, renowned for its innovative treatments for central nervous system (CNS) disorders. With a..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 30.82% Potential Upside for Investors

HealthEquity, Inc. (NASDAQ: HQY), a notable player in the healthcare sector under the Health Information Services industry, presents a compelling case for investors focusing on growth potential. With a market..

Medtronic plc (MDT) Stock Analysis: Discovering a Potential 22% Upside in the Medical Device Giant

Medtronic plc (MDT), a formidable player in the healthcare sector, specifically within the medical devices industry, is capturing the attention of investors with a noteworthy potential upside. Headquartered in Galway,..

Insmed Incorporated (INSM) Stock Analysis: Exploring a Potential 101.96% Upside in the Biotech Arena

Insmed Incorporated (Nasdaq: INSM) has emerged as a noteworthy player in the biotechnology sector, captivating investor attention with an impressive potential upside of 101.96%. As the company continues to advance..

Regencell Bioscience Holdings (RGC): Investor Outlook on the TCM Innovator with a $9.31 Billion Market Cap

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a prominent player in the healthcare sector, commands attention with its focus on Traditional Chinese Medicine (TCM) biosciences. Operating out of Hong Kong, the..

Biogen Inc. (BIIB) Stock Analysis: Navigating a 10% Upside Potential with Strategic Collaborations

Biogen Inc. (NASDAQ: BIIB) stands as a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $29.53 billion, Biogen is a significant..

Ionis Pharmaceuticals (IONS) Stock Analysis: A Biotech Powerhouse with 39.43% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands out in the biotechnology sector with its focus on RNA-targeted medicines, offering a robust pipeline and strategic partnerships that position it well for future..

DaVita Inc. (DVA) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential and Market Position

For investors eyeing opportunities within the healthcare sector, DaVita Inc. (NYSE: DVA) stands out as a prominent player in the medical care facilities industry. With a market capitalization of $13.39..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds